ArticleVaccines2024

Optimization and Validation of a Harmonized Protocol for Generating Therapeutic-Grade Dendritic Cells in a Randomized Phase II Clinical Trial, Using Two Varied Antigenic Sources.

Abirami Seetharaman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.